Skip to main content
. 2016 Oct 20;1(3):e000128. doi: 10.1136/bmjgh-2016-000128

TableĀ 1.

Target conditions

Condition Presentations treated in scenario 1 Additional presentations treated in scenario 2
Coronary disease
  • Acute coronary syndrome

  • Follow-up care of people treated for acute MI with IEHK materials

  • Secondary prevention of stable coronary disease

Cerebrovascular disease
  • Acute stroke

  • Follow-up care of people treated for acute stroke with IEHK materials

  • Secondary prevention among people with remote prior stroke

Heart failure
  • Acute presentation of heart failure

  • Follow-up care of people treated for acute heart failure with IEHK materials

  • Management of stable heart failure

Hypertension
  • Hypertensive urgency or emergency

  • Management of stable hypertension

Diabetes
  • Acute severe hyperglycaemia

  • Severe hypoglycaemia

  • Management of stable diabetes

Chronic lung disease
  • COPD exacerbation

  • Asthma exacerbation

  • Follow-up care of people treated for acute exacerbation of asthma/COPD with IEHK materials

  • Management of stable COPD and asthma

Scenario 1 includes only acute presentations of NCDs. Scenario 2 includes all the presentations in scenario 1 but also the chronic presentations of NCDs in the table. Conditions were assumed to be present in adults only, except for severe hyperglycaemia, severe hypoglycaemia, asthma exacerbation, diabetes, asthma, which were assumed to be present in adults and children.

COPD, chronic obstructive pulmonary disease; IEHK, Interagency Emergency Health Kit; MI, myocardial infarction; NCD, non-communicable disease.